- Report
- June 2023
- 100 Pages
Global
From €5339EUR$5,950USD£4,686GBP
- Drug Pipelines
- December 2022
- 30 Pages
Global
From €2333EUR$2,600USD£2,048GBP
€2916EUR$3,250USD£2,560GBP
- Report
- February 2024
- 120 Pages
Global
From €4262EUR$4,750USD£3,741GBP
- Report
- April 2023
- 120 Pages
Global
From €4262EUR$4,750USD£3,741GBP
- Report
- September 2025
- 150 Pages
Canada
From €3455EUR$3,850USD£3,032GBP
- Training
- 60 Minutes
Global
- Training
- 60 Minutes
Global
- Report
- August 2022
- 541 Pages
Global
From €2243EUR$2,500USD£1,969GBP
- Report
- November 2021
- 1032 Pages
Global
From €4487EUR$5,000USD£3,938GBP
Translational Medicine is a field of biotechnology that focuses on the development of treatments and therapies for diseases and medical conditions. It involves the translation of basic research findings into clinical applications, such as the development of new drugs, diagnostics, and medical devices. Translational Medicine also involves the development of new methods for clinical trials and the evaluation of existing treatments.
The Translational Medicine market is driven by the need for new treatments and therapies for diseases and medical conditions. It is also driven by the need for improved diagnostics and medical devices. The market is expected to grow as new treatments and therapies are developed and as existing treatments are evaluated.
Some companies in the Translational Medicine market include AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more
